nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2D6—Fingolimod—multiple sclerosis	0.0878	0.231	CbGbCtD
Ropivacaine—CYP3A4—Fingolimod—multiple sclerosis	0.0559	0.147	CbGbCtD
Ropivacaine—CYP2B6—Dexamethasone—multiple sclerosis	0.0443	0.116	CbGbCtD
Ropivacaine—SCN3A—spinal nerve—multiple sclerosis	0.038	0.208	CbGeAlD
Ropivacaine—CYP3A4—Methylprednisolone—multiple sclerosis	0.036	0.0945	CbGbCtD
Ropivacaine—CYP3A4—Triamcinolone—multiple sclerosis	0.0273	0.0716	CbGbCtD
Ropivacaine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0263	0.0689	CbGbCtD
Ropivacaine—CYP3A4—Betamethasone—multiple sclerosis	0.0234	0.0615	CbGbCtD
Ropivacaine—CYP3A4—Prednisolone—multiple sclerosis	0.0231	0.0606	CbGbCtD
Ropivacaine—CYP3A4—Prednisone—multiple sclerosis	0.0218	0.0573	CbGbCtD
Ropivacaine—CYP2D6—Dexamethasone—multiple sclerosis	0.0214	0.0562	CbGbCtD
Ropivacaine—SCN8A—peripheral nervous system—multiple sclerosis	0.0154	0.0844	CbGeAlD
Ropivacaine—CYP3A4—Dexamethasone—multiple sclerosis	0.0136	0.0357	CbGbCtD
Ropivacaine—SCN8A—nerve—multiple sclerosis	0.012	0.0658	CbGeAlD
Ropivacaine—SCN10A—peripheral nervous system—multiple sclerosis	0.0103	0.0565	CbGeAlD
Ropivacaine—SCN10A—nerve—multiple sclerosis	0.00803	0.044	CbGeAlD
Ropivacaine—SCN8A—brainstem—multiple sclerosis	0.00515	0.0283	CbGeAlD
Ropivacaine—SCN1A—brainstem—multiple sclerosis	0.00389	0.0214	CbGeAlD
Ropivacaine—SCN2A—brainstem—multiple sclerosis	0.00357	0.0196	CbGeAlD
Ropivacaine—SCN8A—spinal cord—multiple sclerosis	0.0032	0.0176	CbGeAlD
Ropivacaine—SCN9A—midbrain—multiple sclerosis	0.00288	0.0158	CbGeAlD
Ropivacaine—SCN9A—spinal cord—multiple sclerosis	0.00281	0.0154	CbGeAlD
Ropivacaine—SCN1A—medulla oblongata—multiple sclerosis	0.00271	0.0149	CbGeAlD
Ropivacaine—SCN8A—nervous system—multiple sclerosis	0.0027	0.0148	CbGeAlD
Ropivacaine—SCN8A—central nervous system—multiple sclerosis	0.0026	0.0143	CbGeAlD
Ropivacaine—SCN8A—cerebellum—multiple sclerosis	0.00254	0.0139	CbGeAlD
Ropivacaine—SCN2A—medulla oblongata—multiple sclerosis	0.00249	0.0137	CbGeAlD
Ropivacaine—SCN1A—midbrain—multiple sclerosis	0.00248	0.0136	CbGeAlD
Ropivacaine—SCN1A—spinal cord—multiple sclerosis	0.00242	0.0133	CbGeAlD
Ropivacaine—SCN2A—midbrain—multiple sclerosis	0.00228	0.0125	CbGeAlD
Ropivacaine—SCN2A—spinal cord—multiple sclerosis	0.00222	0.0122	CbGeAlD
Ropivacaine—SCN3A—medulla oblongata—multiple sclerosis	0.00219	0.012	CbGeAlD
Ropivacaine—SCN10A—spinal cord—multiple sclerosis	0.00214	0.0118	CbGeAlD
Ropivacaine—SCN4A—nervous system—multiple sclerosis	0.00212	0.0116	CbGeAlD
Ropivacaine—SCN8A—brain—multiple sclerosis	0.00206	0.0113	CbGeAlD
Ropivacaine—SCN1A—nervous system—multiple sclerosis	0.00204	0.0112	CbGeAlD
Ropivacaine—SCN4A—central nervous system—multiple sclerosis	0.00204	0.0112	CbGeAlD
Ropivacaine—SCN3A—midbrain—multiple sclerosis	0.002	0.011	CbGeAlD
Ropivacaine—SCN1A—central nervous system—multiple sclerosis	0.00196	0.0108	CbGeAlD
Ropivacaine—SCN3A—spinal cord—multiple sclerosis	0.00195	0.0107	CbGeAlD
Ropivacaine—SCN1A—cerebellum—multiple sclerosis	0.00192	0.0105	CbGeAlD
Ropivacaine—SCN2A—nervous system—multiple sclerosis	0.00187	0.0103	CbGeAlD
Ropivacaine—SCN9A—brain—multiple sclerosis	0.00181	0.00994	CbGeAlD
Ropivacaine—SCN10A—nervous system—multiple sclerosis	0.00181	0.0099	CbGeAlD
Ropivacaine—SCN2A—central nervous system—multiple sclerosis	0.0018	0.00989	CbGeAlD
Ropivacaine—SCN2A—cerebellum—multiple sclerosis	0.00176	0.00967	CbGeAlD
Ropivacaine—SCN10A—central nervous system—multiple sclerosis	0.00174	0.00954	CbGeAlD
Ropivacaine—SCN3A—nervous system—multiple sclerosis	0.00165	0.00903	CbGeAlD
Ropivacaine—SCN5A—nervous system—multiple sclerosis	0.00164	0.009	CbGeAlD
Ropivacaine—SCN4A—brain—multiple sclerosis	0.00162	0.00887	CbGeAlD
Ropivacaine—SCN3A—central nervous system—multiple sclerosis	0.00158	0.00869	CbGeAlD
Ropivacaine—SCN5A—central nervous system—multiple sclerosis	0.00158	0.00867	CbGeAlD
Ropivacaine—SCN1A—brain—multiple sclerosis	0.00156	0.00855	CbGeAlD
Ropivacaine—SCN3A—cerebellum—multiple sclerosis	0.00155	0.00849	CbGeAlD
Ropivacaine—SCN2A—brain—multiple sclerosis	0.00143	0.00785	CbGeAlD
Ropivacaine—SCN10A—brain—multiple sclerosis	0.00138	0.00757	CbGeAlD
Ropivacaine—SCN3A—brain—multiple sclerosis	0.00126	0.0069	CbGeAlD
Ropivacaine—SCN5A—brain—multiple sclerosis	0.00125	0.00688	CbGeAlD
Ropivacaine—CYP2D6—brainstem—multiple sclerosis	0.00117	0.00644	CbGeAlD
Ropivacaine—CYP2B6—nervous system—multiple sclerosis	0.000828	0.00454	CbGeAlD
Ropivacaine—CYP2B6—central nervous system—multiple sclerosis	0.000797	0.00437	CbGeAlD
Ropivacaine—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000789	0.0086	CbGpPWpGaD
Ropivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000742	0.00809	CbGpPWpGaD
Ropivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000742	0.00809	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000707	0.0077	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000648	0.00707	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000648	0.00707	CbGpPWpGaD
Ropivacaine—CYP2B6—brain—multiple sclerosis	0.000633	0.00347	CbGeAlD
Ropivacaine—CYP3A4—nervous system—multiple sclerosis	0.000625	0.00343	CbGeAlD
Ropivacaine—CYP2D6—nervous system—multiple sclerosis	0.000615	0.00338	CbGeAlD
Ropivacaine—CYP3A4—central nervous system—multiple sclerosis	0.000602	0.0033	CbGeAlD
Ropivacaine—CYP2D6—central nervous system—multiple sclerosis	0.000592	0.00325	CbGeAlD
Ropivacaine—CYP2D6—cerebellum—multiple sclerosis	0.000579	0.00318	CbGeAlD
Ropivacaine—SCN5A—Developmental Biology—CD24—multiple sclerosis	0.000576	0.00627	CbGpPWpGaD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000573	0.00624	CbGpPWpGaD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000573	0.00624	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000556	0.00606	CbGpPWpGaD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000556	0.00606	CbGpPWpGaD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000549	0.00598	CbGpPWpGaD
Ropivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000549	0.00598	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000536	0.00584	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—PRNP—multiple sclerosis	0.000528	0.00576	CbGpPWpGaD
Ropivacaine—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000507	0.00552	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000471	0.00513	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000471	0.00513	CbGpPWpGaD
Ropivacaine—CYP2D6—brain—multiple sclerosis	0.00047	0.00258	CbGeAlD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000465	0.00507	CbGpPWpGaD
Ropivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000465	0.00507	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000451	0.00491	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000451	0.00491	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—PRNP—multiple sclerosis	0.000427	0.00465	CbGpPWpGaD
Ropivacaine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000412	0.00449	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—PTPRC—multiple sclerosis	0.000411	0.00448	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—PRNP—multiple sclerosis	0.000408	0.00445	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000404	0.0044	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—PRNP—multiple sclerosis	0.000392	0.00428	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—PRNP—multiple sclerosis	0.000392	0.00428	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000382	0.00416	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000382	0.00416	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—PRNP—multiple sclerosis	0.000378	0.00412	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—PRNP—multiple sclerosis	0.000378	0.00412	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—PRNP—multiple sclerosis	0.000377	0.00411	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000363	0.00396	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000363	0.00396	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000359	0.00391	CbGpPWpGaD
Ropivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000359	0.00391	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000344	0.00375	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000344	0.00375	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00034	0.0037	CbGpPWpGaD
Ropivacaine—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00034	0.0037	CbGpPWpGaD
Ropivacaine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000335	0.000969	CcSEcCtD
Ropivacaine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000335	0.000969	CcSEcCtD
Ropivacaine—Myalgia—Triamcinolone—multiple sclerosis	0.000333	0.000965	CcSEcCtD
Ropivacaine—Vomiting—Azathioprine—multiple sclerosis	0.000333	0.000964	CcSEcCtD
Ropivacaine—Myalgia—Methylprednisolone—multiple sclerosis	0.000332	0.000963	CcSEcCtD
Ropivacaine—Arthralgia—Methylprednisolone—multiple sclerosis	0.000332	0.000963	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—PTPRC—multiple sclerosis	0.000332	0.00362	CbGpPWpGaD
Ropivacaine—Anxiety—Methylprednisolone—multiple sclerosis	0.000331	0.00096	CcSEcCtD
Ropivacaine—Drowsiness—Methotrexate—multiple sclerosis	0.000331	0.000958	CcSEcCtD
Ropivacaine—Rash—Azathioprine—multiple sclerosis	0.00033	0.000956	CcSEcCtD
Ropivacaine—Dermatitis—Azathioprine—multiple sclerosis	0.00033	0.000956	CcSEcCtD
Ropivacaine—Depression—Methotrexate—multiple sclerosis	0.00033	0.000955	CcSEcCtD
Ropivacaine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000329	0.000954	CcSEcCtD
Ropivacaine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000329	0.000954	CcSEcCtD
Ropivacaine—Discomfort—Triamcinolone—multiple sclerosis	0.000329	0.000954	CcSEcCtD
Ropivacaine—Discomfort—Methylprednisolone—multiple sclerosis	0.000328	0.000951	CcSEcCtD
Ropivacaine—Headache—Azathioprine—multiple sclerosis	0.000328	0.00095	CcSEcCtD
Ropivacaine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000326	0.00355	CbGpPWpGaD
Ropivacaine—Angioedema—Dexamethasone—multiple sclerosis	0.000324	0.00094	CcSEcCtD
Ropivacaine—Angioedema—Betamethasone—multiple sclerosis	0.000324	0.00094	CcSEcCtD
Ropivacaine—Confusional state—Methylprednisolone—multiple sclerosis	0.000321	0.000931	CcSEcCtD
Ropivacaine—Malaise—Betamethasone—multiple sclerosis	0.00032	0.000928	CcSEcCtD
Ropivacaine—Malaise—Dexamethasone—multiple sclerosis	0.00032	0.000928	CcSEcCtD
Ropivacaine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000319	0.000925	CcSEcCtD
Ropivacaine—Vertigo—Dexamethasone—multiple sclerosis	0.000319	0.000924	CcSEcCtD
Ropivacaine—Vertigo—Betamethasone—multiple sclerosis	0.000319	0.000924	CcSEcCtD
Ropivacaine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000319	0.000923	CcSEcCtD
Ropivacaine—Syncope—Dexamethasone—multiple sclerosis	0.000318	0.000922	CcSEcCtD
Ropivacaine—Syncope—Betamethasone—multiple sclerosis	0.000318	0.000922	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—PTPRC—multiple sclerosis	0.000318	0.00346	CbGpPWpGaD
Ropivacaine—Arrhythmia—Prednisone—multiple sclerosis	0.000317	0.000919	CcSEcCtD
Ropivacaine—Infection—Triamcinolone—multiple sclerosis	0.000317	0.000919	CcSEcCtD
Ropivacaine—Infection—Methylprednisolone—multiple sclerosis	0.000316	0.000917	CcSEcCtD
Ropivacaine—Haematuria—Methotrexate—multiple sclerosis	0.000315	0.000913	CcSEcCtD
Ropivacaine—Shock—Triamcinolone—multiple sclerosis	0.000314	0.00091	CcSEcCtD
Ropivacaine—Insomnia—Prednisolone—multiple sclerosis	0.000314	0.00091	CcSEcCtD
Ropivacaine—Shock—Methylprednisolone—multiple sclerosis	0.000313	0.000908	CcSEcCtD
Ropivacaine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000312	0.000904	CcSEcCtD
Ropivacaine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000312	0.000904	CcSEcCtD
Ropivacaine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000312	0.000903	CcSEcCtD
Ropivacaine—Paraesthesia—Prednisolone—multiple sclerosis	0.000312	0.000903	CcSEcCtD
Ropivacaine—Tachycardia—Triamcinolone—multiple sclerosis	0.000312	0.000903	CcSEcCtD
Ropivacaine—Mental disorder—Prednisone—multiple sclerosis	0.000311	0.000901	CcSEcCtD
Ropivacaine—Nausea—Azathioprine—multiple sclerosis	0.000311	0.000901	CcSEcCtD
Ropivacaine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000311	0.000901	CcSEcCtD
Ropivacaine—SCN8A—L1CAM interactions—MAPK1—multiple sclerosis	0.000309	0.00337	CbGpPWpGaD
Ropivacaine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000309	0.000897	CcSEcCtD
Ropivacaine—Erythema—Prednisone—multiple sclerosis	0.000309	0.000896	CcSEcCtD
Ropivacaine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000309	0.000894	CcSEcCtD
Ropivacaine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000308	0.000892	CcSEcCtD
Ropivacaine—Convulsion—Betamethasone—multiple sclerosis	0.000308	0.000891	CcSEcCtD
Ropivacaine—Convulsion—Dexamethasone—multiple sclerosis	0.000308	0.000891	CcSEcCtD
Ropivacaine—Hypertension—Dexamethasone—multiple sclerosis	0.000306	0.000888	CcSEcCtD
Ropivacaine—Hypertension—Betamethasone—multiple sclerosis	0.000306	0.000888	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—PTPRC—multiple sclerosis	0.000305	0.00333	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—PTPRC—multiple sclerosis	0.000305	0.00333	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—PRNP—multiple sclerosis	0.000305	0.00332	CbGpPWpGaD
Ropivacaine—Asthenia—Mitoxantrone—multiple sclerosis	0.000304	0.00088	CcSEcCtD
Ropivacaine—Myalgia—Betamethasone—multiple sclerosis	0.000302	0.000876	CcSEcCtD
Ropivacaine—Myalgia—Dexamethasone—multiple sclerosis	0.000302	0.000876	CcSEcCtD
Ropivacaine—Anxiety—Betamethasone—multiple sclerosis	0.000301	0.000873	CcSEcCtD
Ropivacaine—Anxiety—Dexamethasone—multiple sclerosis	0.000301	0.000873	CcSEcCtD
Ropivacaine—Discomfort—Betamethasone—multiple sclerosis	0.000299	0.000865	CcSEcCtD
Ropivacaine—Discomfort—Dexamethasone—multiple sclerosis	0.000299	0.000865	CcSEcCtD
Ropivacaine—Hypotension—Methylprednisolone—multiple sclerosis	0.000298	0.000863	CcSEcCtD
Ropivacaine—Pain—Prednisolone—multiple sclerosis	0.000297	0.00086	CcSEcCtD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000295	0.00321	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000295	0.00321	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—PTPRC—multiple sclerosis	0.000294	0.00321	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—PTPRC—multiple sclerosis	0.000294	0.00321	CbGpPWpGaD
Ropivacaine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000293	0.000849	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—PTPRC—multiple sclerosis	0.000293	0.00319	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—PRNP—multiple sclerosis	0.000291	0.00318	CbGpPWpGaD
Ropivacaine—Vision blurred—Prednisone—multiple sclerosis	0.000291	0.000844	CcSEcCtD
Ropivacaine—Urethral disorder—Methotrexate—multiple sclerosis	0.000291	0.000843	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000291	0.000843	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00029	0.000841	CcSEcCtD
Ropivacaine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00029	0.000839	CcSEcCtD
Ropivacaine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00029	0.000839	CcSEcCtD
Ropivacaine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00029	0.000839	CcSEcCtD
Ropivacaine—Insomnia—Triamcinolone—multiple sclerosis	0.000289	0.000837	CcSEcCtD
Ropivacaine—Insomnia—Methylprednisolone—multiple sclerosis	0.000288	0.000835	CcSEcCtD
Ropivacaine—Infection—Betamethasone—multiple sclerosis	0.000288	0.000834	CcSEcCtD
Ropivacaine—Infection—Dexamethasone—multiple sclerosis	0.000288	0.000834	CcSEcCtD
Ropivacaine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000287	0.000831	CcSEcCtD
Ropivacaine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000287	0.000831	CcSEcCtD
Ropivacaine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000286	0.000829	CcSEcCtD
Ropivacaine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000286	0.000829	CcSEcCtD
Ropivacaine—Anaemia—Prednisone—multiple sclerosis	0.000286	0.000828	CcSEcCtD
Ropivacaine—Shock—Betamethasone—multiple sclerosis	0.000285	0.000826	CcSEcCtD
Ropivacaine—Shock—Dexamethasone—multiple sclerosis	0.000285	0.000826	CcSEcCtD
Ropivacaine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000285	0.000825	CcSEcCtD
Ropivacaine—Agitation—Prednisone—multiple sclerosis	0.000284	0.000823	CcSEcCtD
Ropivacaine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000284	0.000822	CcSEcCtD
Ropivacaine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000284	0.000822	CcSEcCtD
Ropivacaine—Tachycardia—Betamethasone—multiple sclerosis	0.000283	0.000819	CcSEcCtD
Ropivacaine—Tachycardia—Dexamethasone—multiple sclerosis	0.000283	0.000819	CcSEcCtD
Ropivacaine—Angioedema—Prednisone—multiple sclerosis	0.000282	0.000818	CcSEcCtD
Ropivacaine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000281	0.000814	CcSEcCtD
Ropivacaine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00028	0.000813	CcSEcCtD
Ropivacaine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00028	0.000812	CcSEcCtD
Ropivacaine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00028	0.000812	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—PRNP—multiple sclerosis	0.00028	0.00305	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—PRNP—multiple sclerosis	0.00028	0.00305	CbGpPWpGaD
Ropivacaine—Malaise—Prednisone—multiple sclerosis	0.000279	0.000808	CcSEcCtD
Ropivacaine—Vertigo—Prednisone—multiple sclerosis	0.000278	0.000805	CcSEcCtD
Ropivacaine—Syncope—Prednisone—multiple sclerosis	0.000277	0.000803	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000277	0.00302	CbGpPWpGaD
Ropivacaine—Tinnitus—Methotrexate—multiple sclerosis	0.000277	0.000802	CcSEcCtD
Ropivacaine—Urticaria—Prednisolone—multiple sclerosis	0.000276	0.000799	CcSEcCtD
Ropivacaine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000275	0.000798	CcSEcCtD
Ropivacaine—Pain—Triamcinolone—multiple sclerosis	0.000273	0.000791	CcSEcCtD
Ropivacaine—Loss of consciousness—Prednisone—multiple sclerosis	0.000272	0.000787	CcSEcCtD
Ropivacaine—Hypotension—Dexamethasone—multiple sclerosis	0.000271	0.000784	CcSEcCtD
Ropivacaine—Hypotension—Betamethasone—multiple sclerosis	0.000271	0.000784	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—PRNP—multiple sclerosis	0.00027	0.00294	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—PRNP—multiple sclerosis	0.00027	0.00294	CbGpPWpGaD
Ropivacaine—Vomiting—Mitoxantrone—multiple sclerosis	0.000269	0.00078	CcSEcCtD
Ropivacaine—Convulsion—Prednisone—multiple sclerosis	0.000268	0.000776	CcSEcCtD
Ropivacaine—Hypertension—Prednisone—multiple sclerosis	0.000267	0.000773	CcSEcCtD
Ropivacaine—Rash—Mitoxantrone—multiple sclerosis	0.000267	0.000773	CcSEcCtD
Ropivacaine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000267	0.000772	CcSEcCtD
Ropivacaine—Chills—Methotrexate—multiple sclerosis	0.000266	0.000772	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—PRNP—multiple sclerosis	0.000266	0.0029	CbGpPWpGaD
Ropivacaine—Headache—Mitoxantrone—multiple sclerosis	0.000265	0.000768	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000265	0.00288	CbGpPWpGaD
Ropivacaine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000264	0.000765	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000264	0.000765	CcSEcCtD
Ropivacaine—Arthralgia—Prednisone—multiple sclerosis	0.000263	0.000763	CcSEcCtD
Ropivacaine—Myalgia—Prednisone—multiple sclerosis	0.000263	0.000763	CcSEcCtD
Ropivacaine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000263	0.000762	CcSEcCtD
Ropivacaine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000263	0.000761	CcSEcCtD
Ropivacaine—Anxiety—Prednisone—multiple sclerosis	0.000262	0.00076	CcSEcCtD
Ropivacaine—Insomnia—Betamethasone—multiple sclerosis	0.000262	0.000759	CcSEcCtD
Ropivacaine—Insomnia—Dexamethasone—multiple sclerosis	0.000262	0.000759	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000261	0.000755	CcSEcCtD
Ropivacaine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00026	0.00284	CbGpPWpGaD
Ropivacaine—Paraesthesia—Betamethasone—multiple sclerosis	0.00026	0.000754	CcSEcCtD
Ropivacaine—Paraesthesia—Dexamethasone—multiple sclerosis	0.00026	0.000754	CcSEcCtD
Ropivacaine—Discomfort—Prednisone—multiple sclerosis	0.00026	0.000753	CcSEcCtD
Ropivacaine—Mental disorder—Methotrexate—multiple sclerosis	0.00026	0.000753	CcSEcCtD
Ropivacaine—Erythema—Methotrexate—multiple sclerosis	0.000258	0.000749	CcSEcCtD
Ropivacaine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000256	0.000741	CcSEcCtD
Ropivacaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—multiple sclerosis	0.000256	0.00279	CbGpPWpGaD
Ropivacaine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000255	0.000739	CcSEcCtD
Ropivacaine—Dyspepsia—Betamethasone—multiple sclerosis	0.000255	0.000739	CcSEcCtD
Ropivacaine—Urticaria—Triamcinolone—multiple sclerosis	0.000254	0.000735	CcSEcCtD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000254	0.00276	CbGpPWpGaD
Ropivacaine—Urticaria—Methylprednisolone—multiple sclerosis	0.000253	0.000733	CcSEcCtD
Ropivacaine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000252	0.000731	CcSEcCtD
Ropivacaine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000252	0.000731	CcSEcCtD
Ropivacaine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000252	0.00073	CcSEcCtD
Ropivacaine—Nausea—Mitoxantrone—multiple sclerosis	0.000251	0.000728	CcSEcCtD
Ropivacaine—Infection—Prednisone—multiple sclerosis	0.000251	0.000726	CcSEcCtD
Ropivacaine—SCN9A—L1CAM interactions—MAPK1—multiple sclerosis	0.00025	0.00273	CbGpPWpGaD
Ropivacaine—Back pain—Methotrexate—multiple sclerosis	0.00025	0.000724	CcSEcCtD
Ropivacaine—Shock—Prednisone—multiple sclerosis	0.000248	0.000719	CcSEcCtD
Ropivacaine—Pain—Dexamethasone—multiple sclerosis	0.000248	0.000718	CcSEcCtD
Ropivacaine—Pain—Betamethasone—multiple sclerosis	0.000248	0.000718	CcSEcCtD
Ropivacaine—Tachycardia—Prednisone—multiple sclerosis	0.000246	0.000713	CcSEcCtD
Ropivacaine—Skin disorder—Prednisone—multiple sclerosis	0.000245	0.00071	CcSEcCtD
Ropivacaine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000244	0.000707	CcSEcCtD
Ropivacaine—Vision blurred—Methotrexate—multiple sclerosis	0.000243	0.000705	CcSEcCtD
Ropivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000243	0.00265	CbGpPWpGaD
Ropivacaine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00024	0.000695	CcSEcCtD
Ropivacaine—SCN3A—L1CAM interactions—MAPK1—multiple sclerosis	0.000239	0.00261	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000239	0.00261	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000239	0.00261	CbGpPWpGaD
Ropivacaine—Anaemia—Methotrexate—multiple sclerosis	0.000239	0.000692	CcSEcCtD
Ropivacaine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000239	0.000692	CcSEcCtD
Ropivacaine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000239	0.000692	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—PTPRC—multiple sclerosis	0.000237	0.00258	CbGpPWpGaD
Ropivacaine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000237	0.000686	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000237	0.000686	CcSEcCtD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000236	0.00257	CbGpPWpGaD
Ropivacaine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000236	0.00257	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000235	0.000682	CcSEcCtD
Ropivacaine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000235	0.00068	CcSEcCtD
Ropivacaine—Malaise—Methotrexate—multiple sclerosis	0.000233	0.000675	CcSEcCtD
Ropivacaine—Vertigo—Methotrexate—multiple sclerosis	0.000232	0.000673	CcSEcCtD
Ropivacaine—Urticaria—Betamethasone—multiple sclerosis	0.00023	0.000667	CcSEcCtD
Ropivacaine—Urticaria—Dexamethasone—multiple sclerosis	0.00023	0.000667	CcSEcCtD
Ropivacaine—SCN4A—L1CAM interactions—MAPK1—multiple sclerosis	0.00023	0.00251	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—MAPK1—multiple sclerosis	0.00023	0.00251	CbGpPWpGaD
Ropivacaine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00023	0.000666	CcSEcCtD
Ropivacaine—Dizziness—Prednisolone—multiple sclerosis	0.00023	0.000665	CcSEcCtD
Ropivacaine—Asthenia—Triamcinolone—multiple sclerosis	0.000229	0.000664	CcSEcCtD
Ropivacaine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000229	0.000664	CcSEcCtD
Ropivacaine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000229	0.000664	CcSEcCtD
Ropivacaine—Abdominal pain—Betamethasone—multiple sclerosis	0.000229	0.000664	CcSEcCtD
Ropivacaine—Body temperature increased—Betamethasone—multiple sclerosis	0.000229	0.000664	CcSEcCtD
Ropivacaine—Asthenia—Methylprednisolone—multiple sclerosis	0.000229	0.000662	CcSEcCtD
Ropivacaine—Insomnia—Prednisone—multiple sclerosis	0.000228	0.000661	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—PTPRC—multiple sclerosis	0.000227	0.00247	CbGpPWpGaD
Ropivacaine—Paraesthesia—Prednisone—multiple sclerosis	0.000227	0.000656	CcSEcCtD
Ropivacaine—Pruritus—Triamcinolone—multiple sclerosis	0.000226	0.000655	CcSEcCtD
Ropivacaine—Cough—Methotrexate—multiple sclerosis	0.000225	0.000653	CcSEcCtD
Ropivacaine—Pruritus—Methylprednisolone—multiple sclerosis	0.000225	0.000653	CcSEcCtD
Ropivacaine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000224	0.00244	CbGpPWpGaD
Ropivacaine—Convulsion—Methotrexate—multiple sclerosis	0.000224	0.000649	CcSEcCtD
Ropivacaine—Dyspepsia—Prednisone—multiple sclerosis	0.000222	0.000644	CcSEcCtD
Ropivacaine—SCN1A—L1CAM interactions—MAPK1—multiple sclerosis	0.000222	0.00242	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—MAPK1—multiple sclerosis	0.000222	0.00242	CbGpPWpGaD
Ropivacaine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000221	0.0024	CbGpPWpGaD
Ropivacaine—Myalgia—Methotrexate—multiple sclerosis	0.00022	0.000637	CcSEcCtD
Ropivacaine—Arthralgia—Methotrexate—multiple sclerosis	0.00022	0.000637	CcSEcCtD
Ropivacaine—Chest pain—Methotrexate—multiple sclerosis	0.00022	0.000637	CcSEcCtD
Ropivacaine—Rash—Prednisolone—multiple sclerosis	0.000219	0.000634	CcSEcCtD
Ropivacaine—Dermatitis—Prednisolone—multiple sclerosis	0.000219	0.000634	CcSEcCtD
Ropivacaine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000218	0.000632	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—PTPRC—multiple sclerosis	0.000218	0.00237	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—PTPRC—multiple sclerosis	0.000218	0.00237	CbGpPWpGaD
Ropivacaine—Headache—Prednisolone—multiple sclerosis	0.000218	0.00063	CcSEcCtD
Ropivacaine—Discomfort—Methotrexate—multiple sclerosis	0.000217	0.00063	CcSEcCtD
Ropivacaine—Constipation—Prednisone—multiple sclerosis	0.000216	0.000625	CcSEcCtD
Ropivacaine—Confusional state—Methotrexate—multiple sclerosis	0.000213	0.000616	CcSEcCtD
Ropivacaine—Dizziness—Triamcinolone—multiple sclerosis	0.000211	0.000612	CcSEcCtD
Ropivacaine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000211	0.000611	CcSEcCtD
Ropivacaine—Dizziness—Methylprednisolone—multiple sclerosis	0.000211	0.00061	CcSEcCtD
Ropivacaine—SCN10A—Developmental Biology—PTPRC—multiple sclerosis	0.00021	0.00229	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—PTPRC—multiple sclerosis	0.00021	0.00229	CbGpPWpGaD
Ropivacaine—Infection—Methotrexate—multiple sclerosis	0.000209	0.000607	CcSEcCtD
Ropivacaine—Feeling abnormal—Prednisone—multiple sclerosis	0.000208	0.000602	CcSEcCtD
Ropivacaine—Asthenia—Betamethasone—multiple sclerosis	0.000208	0.000602	CcSEcCtD
Ropivacaine—Asthenia—Dexamethasone—multiple sclerosis	0.000208	0.000602	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—PTPRC—multiple sclerosis	0.000207	0.00226	CbGpPWpGaD
Ropivacaine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000206	0.000598	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000206	0.000598	CcSEcCtD
Ropivacaine—Nausea—Prednisolone—multiple sclerosis	0.000206	0.000598	CcSEcCtD
Ropivacaine—Pruritus—Betamethasone—multiple sclerosis	0.000205	0.000594	CcSEcCtD
Ropivacaine—Pruritus—Dexamethasone—multiple sclerosis	0.000205	0.000594	CcSEcCtD
Ropivacaine—Skin disorder—Methotrexate—multiple sclerosis	0.000205	0.000593	CcSEcCtD
Ropivacaine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000204	0.000591	CcSEcCtD
Ropivacaine—Vomiting—Triamcinolone—multiple sclerosis	0.000203	0.000588	CcSEcCtD
Ropivacaine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000203	0.00221	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000203	0.00221	CbGpPWpGaD
Ropivacaine—Vomiting—Methylprednisolone—multiple sclerosis	0.000203	0.000587	CcSEcCtD
Ropivacaine—Rash—Triamcinolone—multiple sclerosis	0.000201	0.000583	CcSEcCtD
Ropivacaine—Dermatitis—Triamcinolone—multiple sclerosis	0.000201	0.000583	CcSEcCtD
Ropivacaine—Rash—Methylprednisolone—multiple sclerosis	0.000201	0.000582	CcSEcCtD
Ropivacaine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000201	0.000581	CcSEcCtD
Ropivacaine—Urticaria—Prednisone—multiple sclerosis	0.0002	0.000581	CcSEcCtD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.0002	0.00218	CbGpPWpGaD
Ropivacaine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.0002	0.00218	CbGpPWpGaD
Ropivacaine—Headache—Triamcinolone—multiple sclerosis	0.0002	0.00058	CcSEcCtD
Ropivacaine—Headache—Methylprednisolone—multiple sclerosis	0.0002	0.000578	CcSEcCtD
Ropivacaine—Body temperature increased—Prednisone—multiple sclerosis	0.000199	0.000578	CcSEcCtD
Ropivacaine—Abdominal pain—Prednisone—multiple sclerosis	0.000199	0.000578	CcSEcCtD
Ropivacaine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000198	0.000574	CcSEcCtD
Ropivacaine—Diarrhoea—Betamethasone—multiple sclerosis	0.000198	0.000574	CcSEcCtD
Ropivacaine—Hypotension—Methotrexate—multiple sclerosis	0.000197	0.000571	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000192	0.000557	CcSEcCtD
Ropivacaine—Dizziness—Betamethasone—multiple sclerosis	0.000192	0.000555	CcSEcCtD
Ropivacaine—Dizziness—Dexamethasone—multiple sclerosis	0.000192	0.000555	CcSEcCtD
Ropivacaine—Insomnia—Methotrexate—multiple sclerosis	0.000191	0.000553	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—PRNP—multiple sclerosis	0.00019	0.00207	CbGpPWpGaD
Ropivacaine—Nausea—Triamcinolone—multiple sclerosis	0.00019	0.00055	CcSEcCtD
Ropivacaine—Paraesthesia—Methotrexate—multiple sclerosis	0.000189	0.000549	CcSEcCtD
Ropivacaine—Nausea—Methylprednisolone—multiple sclerosis	0.000189	0.000548	CcSEcCtD
Ropivacaine—Dyspnoea—Methotrexate—multiple sclerosis	0.000188	0.000545	CcSEcCtD
Ropivacaine—Somnolence—Methotrexate—multiple sclerosis	0.000187	0.000543	CcSEcCtD
Ropivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000187	0.00204	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Prednisone—multiple sclerosis	0.000186	0.000539	CcSEcCtD
Ropivacaine—Dyspepsia—Methotrexate—multiple sclerosis	0.000186	0.000538	CcSEcCtD
Ropivacaine—Vomiting—Dexamethasone—multiple sclerosis	0.000184	0.000534	CcSEcCtD
Ropivacaine—Vomiting—Betamethasone—multiple sclerosis	0.000184	0.000534	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—TYK2—multiple sclerosis	0.000184	0.002	CbGpPWpGaD
Ropivacaine—Rash—Betamethasone—multiple sclerosis	0.000183	0.000529	CcSEcCtD
Ropivacaine—Rash—Dexamethasone—multiple sclerosis	0.000183	0.000529	CcSEcCtD
Ropivacaine—Dermatitis—Betamethasone—multiple sclerosis	0.000182	0.000529	CcSEcCtD
Ropivacaine—Dermatitis—Dexamethasone—multiple sclerosis	0.000182	0.000529	CcSEcCtD
Ropivacaine—Headache—Dexamethasone—multiple sclerosis	0.000181	0.000526	CcSEcCtD
Ropivacaine—Headache—Betamethasone—multiple sclerosis	0.000181	0.000526	CcSEcCtD
Ropivacaine—Asthenia—Prednisone—multiple sclerosis	0.000181	0.000525	CcSEcCtD
Ropivacaine—Pain—Methotrexate—multiple sclerosis	0.00018	0.000522	CcSEcCtD
Ropivacaine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00018	0.00196	CbGpPWpGaD
Ropivacaine—Pruritus—Prednisone—multiple sclerosis	0.000179	0.000517	CcSEcCtD
Ropivacaine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000174	0.000503	CcSEcCtD
Ropivacaine—Diarrhoea—Prednisone—multiple sclerosis	0.000173	0.0005	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000172	0.0005	CcSEcCtD
Ropivacaine—Nausea—Betamethasone—multiple sclerosis	0.000172	0.000499	CcSEcCtD
Ropivacaine—Nausea—Dexamethasone—multiple sclerosis	0.000172	0.000499	CcSEcCtD
Ropivacaine—Urticaria—Methotrexate—multiple sclerosis	0.000168	0.000485	CcSEcCtD
Ropivacaine—Dizziness—Prednisone—multiple sclerosis	0.000167	0.000483	CcSEcCtD
Ropivacaine—Abdominal pain—Methotrexate—multiple sclerosis	0.000167	0.000483	CcSEcCtD
Ropivacaine—Body temperature increased—Methotrexate—multiple sclerosis	0.000167	0.000483	CcSEcCtD
Ropivacaine—Vomiting—Prednisone—multiple sclerosis	0.00016	0.000465	CcSEcCtD
Ropivacaine—Rash—Prednisone—multiple sclerosis	0.000159	0.000461	CcSEcCtD
Ropivacaine—Dermatitis—Prednisone—multiple sclerosis	0.000159	0.000461	CcSEcCtD
Ropivacaine—Headache—Prednisone—multiple sclerosis	0.000158	0.000458	CcSEcCtD
Ropivacaine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000157	0.00171	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000157	0.00171	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	0.000156	0.0017	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000155	0.00045	CcSEcCtD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000154	0.00168	CbGpPWpGaD
Ropivacaine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000154	0.00168	CbGpPWpGaD
Ropivacaine—Asthenia—Methotrexate—multiple sclerosis	0.000151	0.000438	CcSEcCtD
Ropivacaine—Nausea—Prednisone—multiple sclerosis	0.00015	0.000434	CcSEcCtD
Ropivacaine—Pruritus—Methotrexate—multiple sclerosis	0.000149	0.000432	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—TYK2—multiple sclerosis	0.000149	0.00162	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	0.000148	0.00161	CbGpPWpGaD
Ropivacaine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000146	0.00159	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MMP9—multiple sclerosis	0.000145	0.00158	CbGpPWpGaD
Ropivacaine—Diarrhoea—Methotrexate—multiple sclerosis	0.000144	0.000418	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—TYK2—multiple sclerosis	0.000142	0.00155	CbGpPWpGaD
Ropivacaine—Dizziness—Methotrexate—multiple sclerosis	0.000139	0.000404	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000139	0.00151	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—TYK2—multiple sclerosis	0.000137	0.00149	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—TYK2—multiple sclerosis	0.000137	0.00149	CbGpPWpGaD
Ropivacaine—Vomiting—Methotrexate—multiple sclerosis	0.000134	0.000388	CcSEcCtD
Ropivacaine—Rash—Methotrexate—multiple sclerosis	0.000133	0.000385	CcSEcCtD
Ropivacaine—Dermatitis—Methotrexate—multiple sclerosis	0.000133	0.000385	CcSEcCtD
Ropivacaine—Headache—Methotrexate—multiple sclerosis	0.000132	0.000383	CcSEcCtD
Ropivacaine—SCN10A—Axon guidance—TYK2—multiple sclerosis	0.000132	0.00144	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—TYK2—multiple sclerosis	0.000132	0.00144	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TYK2—multiple sclerosis	0.000131	0.00143	CbGpPWpGaD
Ropivacaine—Nausea—Methotrexate—multiple sclerosis	0.000125	0.000363	CcSEcCtD
Ropivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000125	0.00136	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MMP9—multiple sclerosis	0.000117	0.00128	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—MAPK1—multiple sclerosis	0.000117	0.00127	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MMP9—multiple sclerosis	0.000112	0.00122	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000109	0.00119	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MMP9—multiple sclerosis	0.000108	0.00117	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MMP9—multiple sclerosis	0.000108	0.00117	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TYK2—multiple sclerosis	0.000106	0.00116	CbGpPWpGaD
Ropivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000106	0.00115	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MMP9—multiple sclerosis	0.000104	0.00113	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MMP9—multiple sclerosis	0.000104	0.00113	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MMP9—multiple sclerosis	0.000103	0.00113	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TYK2—multiple sclerosis	0.000101	0.00111	CbGpPWpGaD
Ropivacaine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000101	0.00111	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000101	0.0011	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TYK2—multiple sclerosis	9.75e-05	0.00106	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TYK2—multiple sclerosis	9.75e-05	0.00106	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	9.72e-05	0.00106	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	9.69e-05	0.00106	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MAPK1—multiple sclerosis	9.46e-05	0.00103	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TYK2—multiple sclerosis	9.4e-05	0.00102	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TYK2—multiple sclerosis	9.4e-05	0.00102	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—TYK2—multiple sclerosis	9.26e-05	0.00101	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—STAT3—multiple sclerosis	9.18e-05	0.001	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MAPK1—multiple sclerosis	9.05e-05	0.000986	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—IL6—multiple sclerosis	8.99e-05	0.00098	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—MAPK1—multiple sclerosis	8.69e-05	0.000947	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MAPK1—multiple sclerosis	8.69e-05	0.000947	CbGpPWpGaD
Ropivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.59e-05	0.000936	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TGFB1—multiple sclerosis	8.51e-05	0.000928	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MAPK1—multiple sclerosis	8.38e-05	0.000914	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—MAPK1—multiple sclerosis	8.38e-05	0.000914	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—SRM—multiple sclerosis	8.36e-05	0.000911	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MMP9—multiple sclerosis	8.35e-05	0.00091	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—MAPK1—multiple sclerosis	8.35e-05	0.00091	CbGpPWpGaD
Ropivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.18e-05	0.000891	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	8.13e-05	0.000886	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MMP9—multiple sclerosis	7.99e-05	0.000871	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—TNF—multiple sclerosis	7.95e-05	0.000866	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.79e-05	0.000849	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.79e-05	0.000849	CbGpPWpGaD
Ropivacaine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	7.75e-05	0.000845	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP9—multiple sclerosis	7.67e-05	0.000836	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP9—multiple sclerosis	7.67e-05	0.000836	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	7.57e-05	0.000826	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	7.56e-05	0.000824	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—STAT3—multiple sclerosis	7.43e-05	0.000809	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.41e-05	0.000808	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP9—multiple sclerosis	7.4e-05	0.000807	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP9—multiple sclerosis	7.4e-05	0.000807	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP9—multiple sclerosis	7.29e-05	0.000795	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—IL6—multiple sclerosis	7.27e-05	0.000792	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—STAT3—multiple sclerosis	7.1e-05	0.000774	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	7.06e-05	0.000769	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	7.06e-05	0.000769	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—IL6—multiple sclerosis	6.95e-05	0.000758	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TGFB1—multiple sclerosis	6.88e-05	0.00075	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—STAT3—multiple sclerosis	6.82e-05	0.000744	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—STAT3—multiple sclerosis	6.82e-05	0.000744	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—MAPK1—multiple sclerosis	6.75e-05	0.000736	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—IL6—multiple sclerosis	6.68e-05	0.000728	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—IL6—multiple sclerosis	6.68e-05	0.000728	CbGpPWpGaD
Ropivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.63e-05	0.000722	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TYK2—multiple sclerosis	6.61e-05	0.00072	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TGFB1—multiple sclerosis	6.58e-05	0.000718	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—STAT3—multiple sclerosis	6.58e-05	0.000717	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—STAT3—multiple sclerosis	6.58e-05	0.000717	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—MAPK1—multiple sclerosis	6.46e-05	0.000704	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—IL6—multiple sclerosis	6.44e-05	0.000702	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—IL6—multiple sclerosis	6.44e-05	0.000702	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—TNF—multiple sclerosis	6.43e-05	0.000701	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—IL6—multiple sclerosis	6.41e-05	0.000699	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TGFB1—multiple sclerosis	6.33e-05	0.000689	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TGFB1—multiple sclerosis	6.33e-05	0.000689	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MAPK1—multiple sclerosis	6.2e-05	0.000676	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MAPK1—multiple sclerosis	6.2e-05	0.000676	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—TNF—multiple sclerosis	6.15e-05	0.00067	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TGFB1—multiple sclerosis	6.1e-05	0.000665	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TGFB1—multiple sclerosis	6.1e-05	0.000665	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MAPK1—multiple sclerosis	5.98e-05	0.000652	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MAPK1—multiple sclerosis	5.98e-05	0.000652	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—TNF—multiple sclerosis	5.91e-05	0.000644	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—TNF—multiple sclerosis	5.91e-05	0.000644	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MAPK1—multiple sclerosis	5.89e-05	0.000642	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	5.89e-05	0.000642	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	5.89e-05	0.000642	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—SRM—multiple sclerosis	5.81e-05	0.000633	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—TNF—multiple sclerosis	5.7e-05	0.000621	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—TNF—multiple sclerosis	5.7e-05	0.000621	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—GPC5—multiple sclerosis	5.39e-05	0.000587	CbGpPWpGaD
Ropivacaine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	5.39e-05	0.000587	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP9—multiple sclerosis	5.2e-05	0.000567	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—IL6—multiple sclerosis	5.19e-05	0.000565	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—IL6—multiple sclerosis	4.96e-05	0.000541	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—SRM—multiple sclerosis	4.92e-05	0.000537	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—IL6—multiple sclerosis	4.77e-05	0.000519	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—IL6—multiple sclerosis	4.77e-05	0.000519	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—STAT3—multiple sclerosis	4.63e-05	0.000504	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—IL6—multiple sclerosis	4.6e-05	0.000501	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—IL6—multiple sclerosis	4.6e-05	0.000501	CbGpPWpGaD
Ropivacaine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	4.56e-05	0.000497	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—IL6—multiple sclerosis	4.53e-05	0.000494	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—RRM1—multiple sclerosis	4.46e-05	0.000487	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	4.29e-05	0.000467	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	4.2e-05	0.000458	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.09e-05	0.000446	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.09e-05	0.000446	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—TNF—multiple sclerosis	4e-05	0.000436	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—SRM—multiple sclerosis	3.8e-05	0.000414	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.74e-05	0.000408	CbGpPWpGaD
Ropivacaine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.52e-05	0.000384	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	3.47e-05	0.000378	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	3.47e-05	0.000378	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.39e-05	0.000369	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—IL6—multiple sclerosis	3.23e-05	0.000352	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—GPC5—multiple sclerosis	3.17e-05	0.000346	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.1e-05	0.000338	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.68e-05	0.000292	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.68e-05	0.000292	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—RRM1—multiple sclerosis	2.63e-05	0.000287	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.56e-05	0.000279	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.45e-05	0.000267	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.04e-05	0.000222	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.03e-05	0.000221	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.78e-05	0.000194	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.75e-05	0.000191	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.6e-05	0.000174	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.54e-05	0.000168	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.51e-05	0.000165	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—POMC—multiple sclerosis	1.33e-05	0.000144	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ALB—multiple sclerosis	1.21e-05	0.000132	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000127	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—APOE—multiple sclerosis	1.07e-05	0.000117	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—POMC—multiple sclerosis	9.21e-06	0.0001	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—APOE—multiple sclerosis	9.08e-06	9.9e-05	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ALB—multiple sclerosis	8.4e-06	9.15e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—POMC—multiple sclerosis	7.8e-06	8.5e-05	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ALB—multiple sclerosis	7.11e-06	7.75e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—APOE—multiple sclerosis	7.01e-06	7.64e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—POMC—multiple sclerosis	6.02e-06	6.56e-05	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ALB—multiple sclerosis	5.49e-06	5.98e-05	CbGpPWpGaD
